Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping

Valneva and partner Pfizer say their experimental Lyme disease vaccine has seen a drop-off in protection after 18 months and will need a booster, though early data suggest that later shot can help.